Answer
Administration-site reactions with Willfact (von Willebrand factor), including infusion-site reactions and inflammation, are common, affecting at least 1 in 100 but fewer than 1 in 10 patients.
Sources for this answer
- Willfact 1000 IU Powder and solvent for solution for injectionLFB Biopharmaceuticals Limited · emc · SmPC §4.8 Undesirable effects · Version 5Document updated
Sources checked